Insmed Stock News & Updates

[WKN: A1JJA3 | Symbol: INSM]

Pivotal-Point Tracking Insmed (INSM): Breakthrough in rare lung disease!

The biopharma company focuses on the development of therapies for severe, rare diseases. On March 23,...

Stocks in Action USA: Insmed, Alcoa, United Therapeutics

Insmed (INSM) – Biotech Stock Poised for Rebound: Analysts Fuel Momentum with 45% Price Potential!...

Insmed Dominates the Respiratory Market – Revenue Expected to More Than Double by 2026!

Insmed (INSM) has specialized as a biopharmaceutical company in the development and marketing of therapies...

Analysts' Top 5 Price Targets of March 30, 2026

Jenoptik [DE000A2NB601] Deutsche Bank reiterates Buy rating and raises the price target from €28...

Insmed's Masterpiece: From Niche Player to Billion-Dollar Heavyweight

Insmed (i.) is a pharmaceutical company that specializes in the development of medications for people...

Insmed: Double Strike in Rare Lung Diseases Unleashes New Billion-Dollar Potential

Insmed Inc. (INSM) is a biotechnology company specializing in therapies for severe and rare diseases....

Stocks in Action USA: Insmed, D.R. Horton, Oklo

Insmed (INSM) – Revenue Explosion from New Drug "Brinsupri": Biotech Specialist on the Cusp of a Decisive...

Insmed Secures EU Approval for Brensocatib – First Indication Offers Peak Revenue Potential of $5 Billion!

The biotech company Insmed (INSM) specializes in the development of medications for the treatment of...